000 01481 a2200373 4500
005 20250517144952.0
264 0 _c20180309
008 201803s 0 0 eng d
022 _a2159-9777
024 7 _a10.1080/02791072.2017.1300360
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReif, Sharon
245 0 0 _aCommercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014.
_h[electronic resource]
260 _bJournal of psychoactive drugs
_c
300 _a102-110 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBuprenorphine
_xadministration & dosage
650 0 4 _aHealth Services Accessibility
_xlegislation & jurisprudence
650 0 4 _aHumans
650 0 4 _aInsurance Coverage
_xstatistics & numerical data
650 0 4 _aInsurance, Health
_xstatistics & numerical data
650 0 4 _aOpiate Substitution Treatment
_xmethods
650 0 4 _aOpioid-Related Disorders
_xrehabilitation
650 0 4 _aPatient Protection and Affordable Care Act
650 0 4 _aPublic Health
650 0 4 _aSurveys and Questionnaires
650 0 4 _aUnited States
700 1 _aCreedon, Timothy B
700 1 _aHorgan, Constance M
700 1 _aStewart, Maureen T
700 1 _aGarnick, Deborah W
773 0 _tJournal of psychoactive drugs
_gvol. 49
_gno. 2
_gp. 102-110
856 4 0 _uhttps://doi.org/10.1080/02791072.2017.1300360
_zAvailable from publisher's website
999 _c27023108
_d27023108